Despite significant progress in cancer treatments, the benefits are not experienced equally across different socioeconomic groups.
Marinomed Biotech AG evaluates possible 10% capital increase with exclusion of statutory subscription rights – Biotech Investments
Marinomed Biotech AG / Key word(s): Corporate Action Marinomed Biotech AG evaluates possible 10% capital increase with exclusion of statutory subscription rights 02-Sep-2024 / 17:46